Cargando…

Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER

OBJECTIVE: To construct a prognostic model that estimates the probability of overall survival for T1 high-grade bladder cancer patients after radical cystectomy. PATIENTS AND METHODS: We enrolled 801 patients diagnosed with T1 high grade and received radical cystectomy from the Surveillance, Epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Xiangpeng, Chen, Luyao, Jiang, Ming, Fu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994665/
https://www.ncbi.nlm.nih.gov/pubmed/35411173
http://dx.doi.org/10.2147/IJGM.S354740
_version_ 1784684153879396352
author Zhan, Xiangpeng
Chen, Luyao
Jiang, Ming
Fu, Bin
author_facet Zhan, Xiangpeng
Chen, Luyao
Jiang, Ming
Fu, Bin
author_sort Zhan, Xiangpeng
collection PubMed
description OBJECTIVE: To construct a prognostic model that estimates the probability of overall survival for T1 high-grade bladder cancer patients after radical cystectomy. PATIENTS AND METHODS: We enrolled 801 patients diagnosed with T1 high grade and received radical cystectomy from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2015). All patients were randomly divided into the development group (n = 561) and validation group (n = 240) with the ratio of 7:3. Cox proportional hazards regression analyses were used to filter variables and the Kaplan–Meier method to evaluate survival outcomes. The results of sensitivity analysis determined the variables in the final model. The performance of the model was internally validated by calibration curves, the receiver operating characteristic (ROC) curves, and the concordance index (C-index). RESULTS: The mean survival months were 56.086 in the development group and 58.21 in the validation group. Six variables including age, marital status, tumour size, tumour sites, region nodes examined, and N stage were incorporated in the final nomogram. The accuracy of the nomogram for prediction of overall survival was estimated by C-index (0.732; 0.712–0.752) and AUC (0.771 for 3-year; 0.766 for 5-year) in the development group. In the validation group, the C-index of the nomogram was 0.752 (0.723–0.781), and AUC was 0.761 for 3-year as well as 0.793 for 5-year. These results all showed better performance than the AJCC stage. Calibration plots for 3- and 5-year overall survival presented good concordance in both the development and validation group. CONCLUSION: We have established a prognostic nomogram that provides a more accurate and relevant individualized probability of overall survival for patients with T1HG bladder transitional cell carcinoma after radical cystectomy. It can contribute to improving patient counselling and treatment selection.
format Online
Article
Text
id pubmed-8994665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89946652022-04-10 Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER Zhan, Xiangpeng Chen, Luyao Jiang, Ming Fu, Bin Int J Gen Med Original Research OBJECTIVE: To construct a prognostic model that estimates the probability of overall survival for T1 high-grade bladder cancer patients after radical cystectomy. PATIENTS AND METHODS: We enrolled 801 patients diagnosed with T1 high grade and received radical cystectomy from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2015). All patients were randomly divided into the development group (n = 561) and validation group (n = 240) with the ratio of 7:3. Cox proportional hazards regression analyses were used to filter variables and the Kaplan–Meier method to evaluate survival outcomes. The results of sensitivity analysis determined the variables in the final model. The performance of the model was internally validated by calibration curves, the receiver operating characteristic (ROC) curves, and the concordance index (C-index). RESULTS: The mean survival months were 56.086 in the development group and 58.21 in the validation group. Six variables including age, marital status, tumour size, tumour sites, region nodes examined, and N stage were incorporated in the final nomogram. The accuracy of the nomogram for prediction of overall survival was estimated by C-index (0.732; 0.712–0.752) and AUC (0.771 for 3-year; 0.766 for 5-year) in the development group. In the validation group, the C-index of the nomogram was 0.752 (0.723–0.781), and AUC was 0.761 for 3-year as well as 0.793 for 5-year. These results all showed better performance than the AJCC stage. Calibration plots for 3- and 5-year overall survival presented good concordance in both the development and validation group. CONCLUSION: We have established a prognostic nomogram that provides a more accurate and relevant individualized probability of overall survival for patients with T1HG bladder transitional cell carcinoma after radical cystectomy. It can contribute to improving patient counselling and treatment selection. Dove 2022-04-05 /pmc/articles/PMC8994665/ /pubmed/35411173 http://dx.doi.org/10.2147/IJGM.S354740 Text en © 2022 Zhan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhan, Xiangpeng
Chen, Luyao
Jiang, Ming
Fu, Bin
Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title_full Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title_fullStr Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title_full_unstemmed Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title_short Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER
title_sort development and validation of a prognostic nomogram for predicting overall survival for t1 high-grade patients after radical cystectomy: a study based on seer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994665/
https://www.ncbi.nlm.nih.gov/pubmed/35411173
http://dx.doi.org/10.2147/IJGM.S354740
work_keys_str_mv AT zhanxiangpeng developmentandvalidationofaprognosticnomogramforpredictingoverallsurvivalfort1highgradepatientsafterradicalcystectomyastudybasedonseer
AT chenluyao developmentandvalidationofaprognosticnomogramforpredictingoverallsurvivalfort1highgradepatientsafterradicalcystectomyastudybasedonseer
AT jiangming developmentandvalidationofaprognosticnomogramforpredictingoverallsurvivalfort1highgradepatientsafterradicalcystectomyastudybasedonseer
AT fubin developmentandvalidationofaprognosticnomogramforpredictingoverallsurvivalfort1highgradepatientsafterradicalcystectomyastudybasedonseer